IL101281A0 - Anti-cancer compounds and compositions - Google Patents

Anti-cancer compounds and compositions

Info

Publication number
IL101281A0
IL101281A0 IL101281A IL10128192A IL101281A0 IL 101281 A0 IL101281 A0 IL 101281A0 IL 101281 A IL101281 A IL 101281A IL 10128192 A IL10128192 A IL 10128192A IL 101281 A0 IL101281 A0 IL 101281A0
Authority
IL
Israel
Prior art keywords
compositions
cancer compounds
cancer
compounds
Prior art date
Application number
IL101281A
Other languages
English (en)
Original Assignee
British Tech Group
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group, Ici Plc filed Critical British Tech Group
Publication of IL101281A0 publication Critical patent/IL101281A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL101281A 1991-03-19 1992-03-18 Anti-cancer compounds and compositions IL101281A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919105771A GB9105771D0 (en) 1991-03-19 1991-03-19 Anti-cancer compounds

Publications (1)

Publication Number Publication Date
IL101281A0 true IL101281A0 (en) 1992-11-15

Family

ID=10691801

Family Applications (1)

Application Number Title Priority Date Filing Date
IL101281A IL101281A0 (en) 1991-03-19 1992-03-18 Anti-cancer compounds and compositions

Country Status (18)

Country Link
US (1) US5444061A (https=)
EP (1) EP0509643A1 (https=)
JP (1) JPH06505974A (https=)
AU (1) AU655970B2 (https=)
CA (1) CA2106583A1 (https=)
CZ (1) CZ195393A3 (https=)
FI (1) FI934106A7 (https=)
GB (2) GB9105771D0 (https=)
HU (1) HUT67177A (https=)
IE (1) IE920853A1 (https=)
IL (1) IL101281A0 (https=)
MX (1) MX9201183A (https=)
NO (1) NO933341L (https=)
NZ (1) NZ242023A (https=)
SK (1) SK100993A3 (https=)
TW (1) TW203608B (https=)
WO (1) WO1992016512A1 (https=)
ZA (1) ZA921985B (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9205907D0 (en) * 1992-03-18 1992-04-29 Cancer Res Inst Royal Anti-cancer compounds
GB9223352D0 (en) * 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
GB9408936D0 (en) * 1994-05-05 1994-06-22 Cancer Res Inst Anti-cancer compounds
BR9610422A (pt) * 1995-08-30 1999-07-13 Searle & Co Derivados de meta-guanidina uréia tiouréia ou ácido aminobenzóico azacíclico como antagonistas de integrina
GB9904275D0 (en) 1999-02-24 1999-04-21 Cancer Res Campaign Tech Anti-cancer compounds
US6545004B1 (en) * 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
US7671200B2 (en) * 1999-10-27 2010-03-02 Cytokinetics, Inc. Quinazolinone KSP inhibitors
US7230000B1 (en) 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
WO2003070701A2 (en) * 2002-02-15 2003-08-28 Cytokinetics, Inc. Syntheses of quinazolinones
US7214800B2 (en) * 2002-05-09 2007-05-08 Cytokinetics, Inc. Compounds, compositions, and methods
CA2485148A1 (en) * 2002-05-09 2003-11-20 Cytokinetics, Inc. Pyrimidinone compounds, compositions and methods
EP1513820A4 (en) * 2002-05-23 2006-09-13 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
WO2003106426A1 (en) * 2002-06-14 2003-12-24 Cytokinetics, Inc. Compounds, compositions, and methods
US20030236430A1 (en) * 2002-06-21 2003-12-25 Allen David Robert Preparation of protected amino acids
AU2003256805A1 (en) * 2002-07-23 2004-02-09 Cytokinetics, Inc. Compounds compositions and methods
US20040048853A1 (en) * 2002-08-21 2004-03-11 Gustave Bergnes Compounds, compositions, and methods
WO2004034972A2 (en) 2002-09-30 2004-04-29 Cytokinetics, Inc. Compounds, compositions, and methods
JP2007510652A (ja) * 2003-11-03 2007-04-26 サイトキネティクス・インコーポレーテッド ピリミジン−４−オン化合物、組成物、および方法
EP1680420A4 (en) * 2003-11-07 2008-09-24 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
EP1692112A4 (en) * 2003-12-08 2008-09-24 Cytokinetics Inc COMPOUNDS, COMPOSITIONS, AND METHODS
DK2150514T3 (en) 2007-04-11 2019-02-18 Merck & Cie 18F-LABELED FOLATES
KR102431436B1 (ko) 2014-08-29 2022-08-10 테스 파마 에스.알.엘. α-아미노-β-카복시뮤콘산 세미알데히드 데카복실라제의 억제제
US12030875B2 (en) 2018-09-07 2024-07-09 PIC Therapeutics, Inc. EIF4E inhibitors and uses thereof
AU2021230289A1 (en) 2020-03-03 2022-09-29 PIC Therapeutics, Inc. eIF4E inhibitors and uses thereof
JP2024534127A (ja) 2021-08-25 2024-09-18 ピク セラピューティクス， インコーポレイテッド ｅＩＦ４Ｅ阻害剤及びその使用
US12157732B2 (en) 2021-08-25 2024-12-03 PIC Therapeutics, Inc. eIF4E inhibitors and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3069468D1 (en) * 1979-12-19 1984-11-22 Nat Res Dev Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
GB8513754D0 (en) * 1985-05-31 1985-07-03 Jones T R Anti-cancer quinazoline derivatives
US4746659A (en) * 1985-12-30 1988-05-24 Sri International Diastereomers of 10-alkyl-10-deazaminopterins and process for preparing the same
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
US5187167A (en) * 1986-03-27 1993-02-16 Imperial Chemical Industries Plc Pharmaceutical compositions comprising quinazolin-4-one derivatives
GB8625019D0 (en) * 1986-10-18 1986-11-19 Wellcome Found Compounds
GB8707053D0 (en) * 1987-03-25 1987-04-29 Ici Plc Anti-tumour agents
US4767761A (en) * 1987-11-04 1988-08-30 Dana-Farber Cancer Institute, Inc. Ornithine derivatives and their use as methotrexate-resistant cell inhibitors
GB8727737D0 (en) * 1987-11-26 1987-12-31 Ici Plc Antitumour agents
GB8809978D0 (en) * 1988-04-27 1988-06-02 Ici Plc Anti-tumour agents
US5252573A (en) * 1988-12-15 1993-10-12 Imperial Chemical Industries Plc Anti-tumor agents
GB8829296D0 (en) * 1988-12-15 1989-01-25 Ici Plc Anti-tumour compounds
US4996207A (en) * 1990-01-18 1991-02-26 Nair Madhavan G Three new non-polyglutamatable deazaaminopterins
DE69111891T2 (de) * 1990-05-17 1996-04-04 Smith & Nephew United Inc Elektrisch leitender und adstringierender Film sowie filmbildende Zusammensetzung zur Verwendung auf der Haut.
IL98167A0 (en) * 1990-05-30 1992-06-21 Ici Plc Anti-tumour quinazoline derivatives,processes for their preparation and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
NZ242023A (en) 1993-12-23
TW203608B (https=) 1993-04-11
HUT67177A (en) 1995-02-28
JPH06505974A (ja) 1994-07-07
HU9302636D0 (en) 1993-12-28
NO933341D0 (no) 1993-09-20
CA2106583A1 (en) 1992-09-20
FI934106A7 (fi) 1993-11-18
GB2253849B (en) 1995-01-18
GB9205906D0 (en) 1992-04-29
NO933341L (no) 1993-11-18
GB9105771D0 (en) 1991-05-01
US5444061A (en) 1995-08-22
AU655970B2 (en) 1995-01-19
FI934106A0 (fi) 1993-09-20
MX9201183A (es) 1994-06-30
ZA921985B (en) 1993-09-20
SK100993A3 (en) 1994-08-10
WO1992016512A1 (en) 1992-10-01
CZ195393A3 (en) 1994-07-13
IE920853A1 (en) 1992-09-23
EP0509643A1 (en) 1992-10-21
AU1371692A (en) 1992-10-21
GB2253849A (en) 1992-09-23

Similar Documents

Publication Publication Date Title
IL101281A0 (en) Anti-cancer compounds and compositions
IL104107A0 (en) New compounds and compositions
NZ244766A (en) Bi-aromatic compounds and pharmaceutical compositions
EP0531650A3 (en) Haircleaning composition
GB9102579D0 (en) Compositions
ZA92342B (en) Lice-repellant compositions
HUT61206A (en) Air-freshing composition
GB9101592D0 (en) Compositions
GB9114099D0 (en) Compositions
GB9101655D0 (en) Compositions
EP0513966A3 (en) Bis-bibenzimidazole composition
GB9119028D0 (en) Composition
GB9220088D0 (en) Compounds and compositions
GB9101654D0 (en) Compositions
ZA922642B (en) Anti-cancer compounds
PH30237A (en) Inseticidal composition
IL98791A0 (en) Anti-cancer pharmaceutical compositions
GB9116920D0 (en) Compositions
GB9110111D0 (en) Compositions
GB9117418D0 (en) Compositions
GB9123044D0 (en) Compositions
GB9102109D0 (en) Compositions
GB9102881D0 (en) Compositions
GB9105197D0 (en) Compositions
GB9123026D0 (en) Compositions